| Net Cash Provided by (Used in) Operating Activities |
$49,550,000 |
USD |
-39% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$32,177,000 |
USD |
70% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
113,872,539 |
shares |
-13% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$17,373,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$49,064,000 |
USD |
-22% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$8,784,000 |
USD |
-44% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$1,019,664,000 |
USD |
-13% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$70,677,000 |
USD |
27% |
Q1 2024 |
Q1 2024 |